SCHEDULE 13D: Saba Capital Discloses 15.86% Stake in Voya Asia Pacific High Dividend Equity Income Fund, Signals Activist Intentions
Activist Investor Filing (Schedule 13D)
Saba Capital Management, L.P. and its affiliates have disclosed a 15.86% beneficial ownership in Voya Asia Pacific High Dividend Equity Income Fund, indicating plans to engage with management and the board to address the fund's discount to net asset value and explore strategic options.
Summary
- Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") have acquired 1,743,761 Common Shares of Voya Asia Pacific High Dividend Equity Income Fund.
- This acquisition represents 15.86% of the Issuer's outstanding common stock, calculated based on 10,994,177 shares outstanding as of August 31, 2024.
- The total cost to acquire these Common Shares was approximately $10,868,108.
- The Reporting Persons state their purpose for the acquisition is investment, believing the Common Shares are undervalued and represent an attractive investment opportunity.
- They intend to engage in discussions with the Issuer's management, Board of Trustees, and other shareholders regarding the Issuer's business, operations, board appointments, governance, performance, management, capitalization, the trading of Common Shares at a discount to Net Asset Value (NAV), strategic plans, and matters related to the fund's open or closed-end nature and potential liquidation.
- The Reporting Persons may propose changes, solicit proxies, or nominate individuals for election to the Board.
Sentiment
Score: 7
Explanation: The filing indicates a significant activist stake with clear intentions to address the fund's discount to NAV and potentially improve governance or strategic direction. This is generally viewed positively by shareholders seeking value realization, though the outcome of activist campaigns is not guaranteed.
Positives
- Saba Capital Management, a known activist investor, believes the Common Shares are undervalued and represent an attractive investment opportunity, potentially signaling future value creation.
- The acquisition of a significant 15.86% stake by an activist investor could lead to increased scrutiny and pressure on management to address the fund's discount to NAV and improve shareholder returns.
Negatives
- The Issuer's Common Shares are currently trading at a discount to its net asset value (NAV), indicating that the market values the fund's assets at less than their intrinsic worth.
Risks
- The Common Shares are trading at a discount to the Issuer's net asset value, which may persist or widen.
- The potential for liquidation of the Issuer is a topic of discussion, which could have various implications for shareholders depending on the terms and timing.
Future Outlook
The Reporting Persons intend to continuously review their investment in the Issuer. Depending on various factors, including discussions with management and the Board, the Issuer's financial position, strategic direction, and market conditions, they may purchase additional Common Shares, sell some or all of their holdings, engage in short selling or hedging, or change their investment intentions. They explicitly state they may propose changes to the Issuer's business, operations, board appointments, governance, management, capitalization, strategic plans, or matters relating to the open or closed end nature of the Issuer or timing of any potential liquidation. They may also solicit proxies or nominate individuals for election to the Board.
Management Comments
- "The Reporting Persons acquired the Common Shares to which this Schedule 13D relates in the ordinary course of business for investment purposes because they believe that the Common Shares are undervalued and represent an attractive investment opportunity."
- "The Reporting Persons may engage in discussions with management, the Board of Trustees... concerning the Reporting Persons' investment... including... matters concerning the Issuer's business, operations, board appointments, governance, performance, management, capitalization, trading of the Common Shares at a discount to the Issuer's net asset value and strategic plans and matters relating to the open or closed end nature of the Issuer and timing of any potential liquidation of the Issuer."
- "The Reporting Persons may also propose or take one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D, including the solicitation of proxies, and may discuss such actions with the Issuer and Issuer's management and the board of trustees, other stockholders of the Issuer and other interested parties."
- "The Reporting Persons may make binding or non-binding shareholder proposals, or may nominate one or more individuals as nominees for election to the Board in connection with their investment in the Common Shares of the Issuer."
Industry Context
This Schedule 13D filing by Saba Capital Management, a prominent activist investor known for targeting closed-end funds, is a common occurrence in the investment management industry. Closed-end funds often trade at a discount to their Net Asset Value (NAV), presenting opportunities for activist investors to acquire significant stakes and advocate for changes to unlock shareholder value. Saba Capital's stated intentions to engage on governance, management, and potential liquidation are typical strategies employed by activists to narrow the NAV discount or realize the fund's underlying asset value.
Related Party Transactions
- A Joint Filing Agreement is attached as Exhibit 1, outlining the agreement among Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein to jointly file the Schedule 13D.
Stakeholder Impact
- **Shareholders**: Potential for increased shareholder value if Saba Capital's activist efforts successfully narrow the discount to NAV, lead to a favorable liquidation, or improve corporate governance and performance.
- **Management and Board**: Likely to face increased pressure and scrutiny from Saba Capital, potentially leading to strategic reviews, operational changes, or board composition adjustments.
- **Employees**: Potential for indirect impact if strategic changes or operational efficiencies are pursued by the fund's management under activist pressure.
Next Steps
- The Reporting Persons may engage in discussions with the Issuer's management, Board of Trustees, other shareholders, and relevant parties.
- They may exchange information with persons pursuant to confidentiality agreements or work together with persons pursuant to joint agreements.
- They may propose changes in the Issuer's business, operations, board appointments, governance, management, capitalization, strategic plans, or matters relating to the open or closed end nature of the Issuer or timing of any potential liquidation.
- They may propose or take actions described in Item 4 of Schedule 13D, including the solicitation of proxies.
- They may make binding or non-binding shareholder proposals.
- They may nominate one or more individuals as nominees for election to the Board.
- They intend to review their investment in the Issuer on a continuing basis.
- They may purchase additional Common Shares or sell some or all of their Common Shares.
- They may engage in short selling of or any hedging or similar transactions with respect to the Common Shares.
- They may otherwise change their intention with respect to any and all matters referred to in Item 4 of Schedule 13D.
Key Dates
| Date | Description |
|---|---|
| 11/16/2015 | Date of power of attorney for Michael D'Angelo, incorporated by reference to Exhibit 2 of the Schedule 13G filed on December 28, 2015. |
| 12/28/2015 | Date of Schedule 13G filing by the Reporting Persons, which incorporated the power of attorney. |
| 08/31/2024 | Date as of which 10,994,177 shares of common stock were outstanding, as disclosed in the company's N-CSRS filed on November 6, 2024. |
| 11/06/2024 | Date of the company's N-CSRS filing disclosing shares outstanding as of August 31, 2024. |
| 04/23/2025 | Trade date for the purchase of 41,790 Common Shares at $6.07. |
| 04/25/2025 | Trade date for the purchase of 4,800 Common Shares at $6.11. |
| 04/28/2025 | Trade date for the purchase of 5,563 Common Shares at $6.09. |
| 05/07/2025 | Date of the event which required the filing of this Schedule 13D/A, and trade date for the purchase of 1,667,910 Common Shares at $6.22. |
| 05/08/2025 | Signature date for the Schedule 13D filing. |
Recommendation
holdKeywords
Saba Capital, Voya Asia Pacific High Dividend Equity Income Fund, Schedule 13D, Activist Investor, Closed-End Fund, Common Shares, Equity Income, Dividend, Undervalued, Corporate Governance, Proxy Solicitation, Board Nomination, Net Asset Value, Liquidation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.